There is increasing evidence that the expression of CD109, a GPI-anchored cell surface
protein is dysregulated in squamous cell carcinoma (SCC). However, the functional role of …

CD109 is a glycosylphosphatidylinositol (GPI)–anchored glycoprotein whose expression is
up‐regulated in squamous cell carcinomas (SCCs) of the lung, esophagus, and uterus. The …

Squamous cell carcinoma (SCC) is well-known for its high rate of metastasis with poor
prognosis. CD109 is a glycosylphosphatidylinositol-anchored cell-surface glycoprotein …

Background CD109 was involved in the tumorigenesis and progression of various cancers
via TGF-β1 signalling and STAT3 activation. As CD109 is strongly expressed in cervical …

Simple Summary Squamous cell carcinoma is a type of cancer resulting from cancer of the
squamous cells that line some organs of the body such as the skin, lungs, and vulva. It is …

CD109 is a glycosylphosphatidylinositol‐anchored glycoprotein and a member of the α2‐
macroglobulin/C3, C4, C5 family of thioester‐containing proteins first identified as being …

CD109 is a glycosylphosphatidylinositol-anchored cell surface protein that is frequently
detected in squamous cell carcinomas. CD109 is a negative regulator of TGF-β1 signaling in …

CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in
several types of human cancers, particularly squamous cell carcinomas. We previously …

Stromal invasion is considered an important prognostic factor in patients with lung
adenocarcinoma. The mechanisms underlying the formation of tumor stroma and stromal …

Cluster of differentiation (CD) 109 is a glycosylphosphatidylinositol‑anchored cell surface
glycoprotein and a co‑receptor for transforming growth factor β. The expression of CD109 …